PDCD1 and hepatocellular carcinoma: Moreover, clinical trials have demonstrated that transcatheter interventional chemoembolization in combination with tyrosine kinase inhibitors(TKI)and programmed cell death protein-1 (PD-1) improves overall survival and disease control rates in advanced HCC (4).